IQVIA Holdings IncNYSE:IQV
- LAST PRICE237.4700
- TODAY'S CHANGE (%)2.5900 (1.1027%)
- Bid / Lots237.2700/ 4
- Ask / Lots237.5700/ 4
- Open / Previous Close236.5500 / 234.8800
- Day Range
- 52 Week Range
- Volume162,058
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IQV |
|---|---|---|
| 09:32 ET | 4713 | 236.55 |
| 09:34 ET | 600 | 236.875 |
| 09:36 ET | 200 | 237.58 |
| 09:38 ET | 100 | 236.7 |
| 09:43 ET | 1863 | 236.66 |
| 09:45 ET | 400 | 236.3 |
| 09:48 ET | 1412 | 236.41 |
| 09:50 ET | 1967 | 236.495 |
| 09:54 ET | 311 | 236.29 |
| 09:56 ET | 300 | 236.1 |
| 09:57 ET | 700 | 235.75 |
| 09:59 ET | 1302 | 236.12 |
| 10:01 ET | 3120 | 236.3 |
| 10:03 ET | 886 | 236.345 |
| 10:06 ET | 736 | 236.15 |
| 10:08 ET | 335 | 236.175 |
| 10:10 ET | 200 | 235.89 |
| 10:12 ET | 721 | 236.375 |
| 10:17 ET | 500 | 236.96 |
| 10:19 ET | 315 | 236.84 |
| 10:21 ET | 789 | 237.19 |
| 10:24 ET | 800 | 237.275 |
| 10:28 ET | 478 | 237.4408 |
| 10:32 ET | 407 | 237.29 |
| 10:33 ET | 827 | 237.22 |
| 10:35 ET | 200 | 237.01 |
| 10:37 ET | 1017 | 236.89 |
| 10:39 ET | 175 | 236.8271 |
| 10:42 ET | 6800 | 236.35 |
| 10:44 ET | 400 | 236.22 |
| 10:46 ET | 2659 | 236.07 |
| 10:50 ET | 800 | 236.19 |
| 10:51 ET | 630 | 235.925 |
| 10:53 ET | 2350 | 235.78 |
| 10:55 ET | 509 | 235.9 |
| 10:57 ET | 600 | 236.18 |
| 11:00 ET | 2187 | 236.27 |
| 11:02 ET | 300 | 236.41 |
| 11:04 ET | 299 | 236.47 |
| 11:06 ET | 500 | 236.425 |
| 11:09 ET | 100 | 236.2 |
| 11:11 ET | 660 | 236.28 |
| 11:13 ET | 990 | 236.2 |
| 11:15 ET | 547 | 236.22 |
| 11:18 ET | 1193 | 236.37 |
| 11:20 ET | 275 | 236.37 |
| 11:22 ET | 806 | 236.205 |
| 11:24 ET | 1000 | 236.3825 |
| 11:26 ET | 604 | 236.39 |
| 11:27 ET | 500 | 236.405 |
| 11:31 ET | 1200 | 236.065 |
| 11:33 ET | 1208 | 235.98 |
| 11:36 ET | 1372 | 236.38 |
| 11:38 ET | 300 | 236.5 |
| 11:40 ET | 400 | 236.7 |
| 11:42 ET | 100 | 236.49 |
| 11:44 ET | 599 | 236.69 |
| 11:45 ET | 400 | 236.54 |
| 11:47 ET | 400 | 236.44 |
| 11:49 ET | 100 | 236.48 |
| 11:51 ET | 900 | 236.69 |
| 11:54 ET | 251 | 236.8 |
| 11:58 ET | 855 | 237.055 |
| 12:00 ET | 1000 | 237.28 |
| 12:02 ET | 900 | 237.18 |
| 12:03 ET | 2152 | 237.62 |
| 12:05 ET | 200 | 237.62 |
| 12:07 ET | 907 | 237.57 |
| 12:09 ET | 100 | 237.4 |
| 12:12 ET | 400 | 237.53 |
| 12:18 ET | 900 | 237.475 |
| 12:20 ET | 911 | 237.27 |
| 12:21 ET | 300 | 237.44 |
| 12:23 ET | 400 | 237.49 |
| 12:25 ET | 301 | 237.21 |
| 12:30 ET | 2348 | 237.26 |
| 12:32 ET | 600 | 237.35 |
| 12:34 ET | 200 | 237.35 |
| 12:36 ET | 1593 | 237.8 |
| 12:38 ET | 200 | 237.655 |
| 12:39 ET | 600 | 237.495 |
| 12:41 ET | 506 | 237.24 |
| 12:43 ET | 800 | 237.56 |
| 12:48 ET | 201 | 237.47 |
Apr 23, 2024
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards, from 9:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
9:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 15, 2024
Press Release: IQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:20PM ET on Monday Apr 15, 2024 by Dow Jones
4:20PM ET on Monday Apr 15, 2024 by Dow JonesIQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:15PM ET on Monday Apr 15, 2024 by Dow Jones
4:15PM ET on Monday Apr 15, 2024 by Dow Jones
Apr 8, 2024
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud, from 4:01PM ET on Monday Apr 08, 2024 by Dow Jones
4:01PM ET on Monday Apr 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IQVIA Holdings Inc | 42.6B | 32.5x | +46.62% |
Biogen Inc | 30.4B | 27.1x | -18.14% |
Moderna Inc | 41.3B | -9.0x | --- |
ICON PLC | 25.4B | 37.2x | +4.68% |
Regeneron Pharmaceuticals Inc | 96.9B | 25.7x | +10.93% |
Grifols SA | 5.5B | 67.2x | --- |
Company Information
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.
Contact Information
- Headquarters
- 2400 ELLIS ROADDURHAM, NC, United States 27703
- Phone
- 919-998-2000
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer
- Ari Bousbib
- Chief Financial Officer, Executive Vice President
- Ronald Bruehlman
- President - Corporate Strategy and Enterprise Networks
- Kevin Knightly
- President - Research and Development Solutions
- Walter Staub
- Executive Vice President, General Counsel, Secretary
- Eric Sherbet
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.6B |
|---|---|
Revenue (TTM) | $15.0B |
Shares Outstanding | 181.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.53 |
EPS | $7.30 |
Book Value | $33.67 |
P/E Ratio | 32.5x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | 17.2x |
Operating Margin | 13.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
